LYOPHILIZEDRetatrutide 10mg
High-purity Retatrutide (10mg per vial) for advanced metabolic research. Triple agonist targeting GLP-1, GIP, and glucagon receptors. Supplied as a lyophilized powder in a sealed, batch-tested vial.
Technical Specifications
- PURITY
- ≥99% (HPLC/MS)
- FORM
- Lyophilized Powder
- VIAL AMOUNT
- 10mg
- CLASSIFICATION
- Synthetic Peptide (RUO)
This product is intended strictly for in-vitro laboratory research. Not for human consumption, diagnostic, therapeutic, or veterinary use. By purchasing, you confirm you are a qualified researcher or institution.
- Ships within 24 hours (Mon–Fri) · US domestic only
- Certificate of Analysis available on request
- Sealed, batch-tested vial with lot number
Product Description
Retatrutide is a novel synthetic peptide engineered as a triple receptor agonist, simultaneously targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. This unique tri-agonist profile makes it a compelling subject for metabolic pathway research.
Each 10mg vial is produced under strict laboratory conditions and verified at ≥99% purity via high-performance liquid chromatography (HPLC) and mass spectrometry (MS). A batch-specific Certificate of Analysis is available with every order.
Handling & Storage
- Store lyophilized vials at -20°C, protected from light.
- Once reconstituted, store at 2–8°C and use within research protocol timelines.
- Avoid repeated freeze-thaw cycles.
- Reconstitute with bacteriostatic water for laboratory applications.